- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Blau Farmaceutica SA (BLAU3)
Assess today's live Blau Farmaceutica SA (BLAU3) share price, performance and insights using our live B3: BLAU3 stock exchange data.
Analyse the historical data and Blau Farmaceutica SA share price performance charts on this page. Our technical summary section provides analysis on Blau Farmaceutica share price buy/sell indicators using real-time data (or discuss the Blau Farmaceutica (BLAU3) stock price today with other investors in the Blau Farmaceutica BVMF share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BVMF BLAU3 share price (ISIN: BRBLAUACNOR8) to enhance your trading decisions with our free investment tools and resources.
What Is the Blau Farmaceutica SA Share Price Today?
The Blau Farmaceutica share price today is 13.02.
What Is the Stock Symbol for Blau Farmaceutica SA
The stock symbol (or 'ticker') for Blau Farmaceutica SA is "BLAU3."
What Stock Exchange Does Blau Farmaceutica SA Trade On?
Blau Farmaceutica SA is listed and trades on the B3 stock exchange.
Is Blau Farmaceutica SA a Good Stock to Buy?
Determining whether Blau Farmaceutica SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Blau Farmaceutica SA share price performance charts on this page. Our technical summary section provides analysis on Blau Farmaceutica share price buy/sell indicators using real-time data (or discuss the Blau Farmaceutica (BLAU3) stock price today with other investors in the Blau Farmaceutica BVMF share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BVMF BLAU3 share price (ISIN: BRBLAUACNOR8) to enhance your trading decisions with our free investment tools and resources.
What Is the Blau Farmaceutica SA Share Price Today?
The Blau Farmaceutica share price today is 13.02.
What Is the Stock Symbol for Blau Farmaceutica SA
The stock symbol (or 'ticker') for Blau Farmaceutica SA is "BLAU3."
What Stock Exchange Does Blau Farmaceutica SA Trade On?
Blau Farmaceutica SA is listed and trades on the B3 stock exchange.
Is Blau Farmaceutica SA a Good Stock to Buy?
Determining whether Blau Farmaceutica SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
13.02
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.93
13.16
52 wk Range
11.48
14.71
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.9313.16
52 wk Range
11.4814.71
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(7.87%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(7.87%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BLAU3 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
16.00
Upside
+22.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
- Blau Farmaceutica receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Blau Farmaceutica receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Blau Farmaceutica Company Profile
Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics products. Blau Farmacêutica S.A. was incorporated in 1987 and is headquartered in Cotia, Brazil.
Blau Farmaceutica SA Earnings Call Summary for Q3/2025
- Blau Farmaceutica missed Q3 2025 forecasts with EPS of $0.3869 (vs $0.4003) and revenue of $485.4M (vs $491.62M), causing a 0.55% stock decline to $12.72.
- Despite flat net revenue of BRL 475M, net income grew 52% YoY to BRL 106M with a 41% gross margin, slightly impacted by a Jamares plasma provision.
- The company plans to launch products worth BRL 700M this year and BRL 1B next year, while expanding its Pernambuco plant with a 60% growth target in product launches.
- CEO Marcelo Hahn emphasized strategic investments to 'capture market opportunities and the drop in patents' while highlighting advances in production lines and monoclonal antibodies.
- Capacity constraints are limiting growth potential, with the company exploring opportunities in the US plasma market while facing a temporary slowdown in the hospital segment.
Last Updated: 05/11/2025, 16:16
Read Full TranscriptCompare BLAU3 to Peers and Sector
Metrics to compare | BLAU3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLAU3PeersSector | |
|---|---|---|---|---|
P/E Ratio | 7.1x | −2.4x | −0.6x | |
PEG Ratio | 0.10 | 0.06 | 0.00 | |
Price/Book | 1.0x | 2.3x | 2.6x | |
Price / LTM Sales | 1.3x | 8.2x | 3.2x | |
Upside (Analyst Target) | 15.2% | 35.4% | 41.8% | |
Fair Value Upside | Unlock | 2.1% | 5.1% | Unlock |
Analyst Ratings
5 Buy
5 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 16.00
(+22.89% Upside)
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
0.4956 / 0.4003
Revenue / Forecast
475.20M / 491.62M
People Also Watch
FAQ
What Is the Blau Farmaceutica (BLAU3) Share Price Today?
The live Blau Farmaceutica share price today is 13.02
What Stock Exchange Does Blau Farmaceutica (BLAU3) Trade On?
Blau Farmaceutica is listed and trades on the B3 Stock Exchange.
What Is the Ticker (Stock Symbol) for Blau Farmaceutica?
The stock symbol (also called a 'ticker') for Blau Farmaceutica is "BLAU3."
Does Blau Farmaceutica Pay Dividends? What’s The Current BLAU3 Dividend Yield?
Yes, BLAU3 Pays Dividends to its Shareholders. The current Blau Farmaceutica dividend yield is 7.87%.
What Is the Current Blau Farmaceutica Market Cap?
As of today, Blau Farmaceutica market capitalisation is 2.31B.
What Is Blau Farmaceutica's (BLAU3) Earnings Per Share (TTM)?
The Blau Farmaceutica EPS is currently 1.82 (Trailing Twelve Months).
When Is the Next Blau Farmaceutica Earnings Date?
Blau Farmaceutica's next earnings report will be released on 25 Mar 2026.
Is BLAU3 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Blau Farmaceutica moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Blau Farmaceutica Stock Split?
Blau Farmaceutica has split 0 times. (See the BLAU3 stock split history page for full effective split date and price information.)
How Many Employees Does Blau Farmaceutica Have?
Blau Farmaceutica has 1900 employees.
What is the current trading status of Blau Farmaceutica (BLAU3)?
As of 24 Dec 2025, Blau Farmaceutica (BLAU3) is trading at a price of 13.02, with a previous close of 13.02. The stock has fluctuated within a day range of 12.93 to 13.16, while its 52-week range spans from 11.48 to 14.71.
What Is Blau Farmaceutica (BLAU3) Price Target According to Analysts?
The average 12-month price target for Blau Farmaceutica is BRL16, with a high estimate of BRL19 and a low estimate of BRL14.5. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +22.89% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.